Advertisement

John Wayne Cancer Institute and Singapore’s Clearbridge BioMedics to establish a circulating tumor cell center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE JOHN WAYNE CANCER INSTITUTE at the St. Johns Health Center, Providence Health Systems in Santa Monica, CA, and Singapore-based Clearbridge BioMedics will work together to establish a Circulating Tumor Cell Center of Research Excellence. This new center builds upon JWCI’s experience in CTC assessment in patients and Clearbridge BioMedics’ expertise in isolating CTCs. The...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Advertisement
Advertisement
Table of Contents
Advertisement
Advertisement

YOU MAY BE INTERESTED IN

The day before health economist Jay Bhattacharya stepped into his new role as NIH director, he sent a document to his employees outlining his top five priorities for the department, which included “reproducibility” and “transparency,” two themes he discussed at his confirmation hearings (The Cancer Letter, March 7, 2025).
Advertisement
Advertisement